STAT News

STAT+: Roivant says closely watched immune drug succeeded in new eye disease

An immune drug from Roivant could be headed to a new market, after the company reported positive trials in the eye disease non-infectious uveitis.

By STAT News

1 min read
STAT+: Roivant says closely watched immune drug succeeded in new eye disease
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights